Material Event Form 8 K

Item 8.01 Other Events.

On July 24, 2024, Nutex Health Inc. (the "Company") received written notice (the "Compliance Notice") from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), as required by the Hearing Panel's June 14, 2024 decision, which was previously disclosed in the Company's Current Report on Form 8-K filed on June 18, 2024.

Nasdaq notified the Company in the Compliance Notice that, from July 3, 2024, the date of the Company's 1:10 reverse stock split, to July 23, 2024, the closing bid price of the Company's common stock had traded above $1.00 per share and, accordingly, the Staff of Nasdaq determined that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2). Accordingly, the Hearing Panel determined to continue the listing of the Company's common stock on The Nasdaq Stock Market and closed this matter.